From: rssfeeds@jmason.org  Fri Oct  4 11:02:15 2002
Return-Path: <rssfeeds@example.com>
Delivered-To: yyyy@localhost.example.com
Received: from localhost (jalapeno [127.0.0.1])
	by jmason.org (Postfix) with ESMTP id 1A03816F18
	for <jm@localhost>; Fri,  4 Oct 2002 11:01:53 +0100 (IST)
Received: from jalapeno [127.0.0.1]
	by localhost with IMAP (fetchmail-5.9.0)
	for jm@localhost (single-drop); Fri, 04 Oct 2002 11:01:53 +0100 (IST)
Received: from dogma.slashnull.org (localhost [127.0.0.1]) by
    dogma.slashnull.org (8.11.6/8.11.6) with ESMTP id g9480pK08858 for
    <jm@jmason.org>; Fri, 4 Oct 2002 09:00:51 +0100
Message-Id: <200210040800.g9480pK08858@dogma.slashnull.org>
To: yyyy@example.com
From: newscientist <rssfeeds@example.com>
Subject: 'Miracle' gene therapy trial halted
Date: Fri, 04 Oct 2002 08:00:51 -0000
Content-Type: text/plain; encoding=utf-8
X-Spam-Status: No, hits=-833.6 required=5.0
	tests=AWL,T_NONSENSE_FROM_40_50
	version=2.50-cvs
X-Spam-Level: 

URL: http://www.newsisfree.com/click/-4,8519920,1440/
Date: Not supplied

A French trial of a highly promising treatment for the fatal "bubble boy" 
disease is stopped after a patient developed leukaemia


